{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:12:49Z","timestamp":1761844369469,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":458,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1593\/tlo.12313","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T09:45:49Z","timestamp":1395740749000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase 1\/2 Activity"],"prefix":"10.1016","volume":"6","author":[{"given":"Elias","family":"Kassab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Timsah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShiHui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur E.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph J.","family":"Abi-Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2012","series-title":"Cancer Facts and Figures 2012","key":"10.1593\/tlo.12313_bib1"},{"key":"10.1593\/tlo.12313_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF03165122","article-title":"The myelodysplastic syndromes: morphology, risk assessment, and clinical management","volume":"2","author":"Bennett","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1593\/tlo.12313_bib3","first-page":"95","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"1999","journal-title":"Curr Opin Chem Biol"},{"key":"10.1593\/tlo.12313_bib4","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1073\/pnas.052707699","article-title":"Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase","volume":"99","author":"Koo","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/tlo.12313_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1535-7163.MCT-05-0145","article-title":"Braf status and mitogen-activated protein\/extracellular signal-regulated kinase kinase 1\/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin","volume":"4","author":"Abi-Habib","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1593\/tlo.12313_bib6","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-03-3433","article-title":"V599EB-Raf is an oncogene in melanocytes","volume":"64","author":"Wellbrock","year":"2004","journal-title":"Cancer Res"},{"key":"10.1593\/tlo.12313_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sj.leu.2402460","article-title":"The Raf\/MEK\/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia","volume":"16","author":"Lee","year":"2002","journal-title":"Leukemia"},{"key":"10.1593\/tlo.12313_bib8","first-page":"511","article-title":"The Ras-Raf-MEK-ERK pathway in the treatment of cancer","volume":"25","author":"Hilger","year":"2002","journal-title":"Onkologie"},{"key":"10.1593\/tlo.12313_bib9","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1158\/0008-5472.CAN-04-0866","article-title":"Blocking the Raf\/MEK\/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1593\/tlo.12313_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI12807","article-title":"Therapeutic targeting of the Mek\/Mapk signal transduction module in acute myeloid leukemia","volume":"108","author":"Milella","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1593\/tlo.12313_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1593\/tlo.12313_bib12","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/tlo.12313_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","article-title":"Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process","volume":"160","author":"Abrami","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1593\/tlo.12313_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1083\/jcb.200507067","article-title":"Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis","volume":"172","author":"Abrami","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1593\/tlo.12313_bib15","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1073\/pnas.0604000103","article-title":"A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation","volume":"103","author":"Melnyk","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/tlo.12313_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1593\/tlo.12313_bib17","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1074\/jbc.M211262200","article-title":"Anthrax lethal factor proteolysis and inactivation of MAPK kinase","volume":"278","author":"Chopra","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1593\/tlo.12313_bib18","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1158\/1078-0432.CCR-06-2019","article-title":"Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice","volume":"12","author":"Abi-Habib","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1593\/tlo.12313_bib19","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1158\/0008-5472.CAN-09-1567","article-title":"Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24\/MKP-7\/MAPK network","volume":"69","author":"Zaidi","year":"2009","journal-title":"Cancer Res"},{"issue":"10","key":"10.1593\/tlo.12313_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00109-012-0886-z","article-title":"Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for \u201cvertical\u201d and \u201clateral\u201d combination strategies","volume":"90","author":"Ricciardi","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"10.1593\/tlo.12313_bib21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/sj.leu.2403828","article-title":"The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells","volume":"19","author":"Konopleva","year":"2005","journal-title":"Leukemia"},{"key":"10.1593\/tlo.12313_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.jim.7000239","article-title":"Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis","volume":"28","author":"Ramirez","year":"2002","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1593\/tlo.12313_bib23","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1074\/jbc.M011085200","article-title":"Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1593\/tlo.12313_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0145-2126(02)00077-2","article-title":"The diphtheria toxin\/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells","volume":"27","author":"Ramage","year":"2003","journal-title":"Leuk Res"},{"key":"10.1593\/tlo.12313_bib25","first-page":"757","article-title":"Single cell analysis of phosphoinositide 3-kinase\/Akt and ERK activation in acute myeloid leukemia by flow cytometry","volume":"91","author":"Bardet","year":"2006","journal-title":"Haematologica"},{"key":"10.1593\/tlo.12313_bib26","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/1078-0432.CCR-11-2381","article-title":"The clinical effect of the dual-targeting strategy involving PI3K\/AKT\/mTOR and RAS\/MEK\/ERK pathways in patients with advanced cancer","volume":"18","author":"Shimizu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1593\/tlo.12313_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jss.2011.10.045","article-title":"PKI-587 and sorafenib targeting PI3K\/AKT\/mTOR and Ras\/Raf\/MAPK pathways synergistically inhibit HCC cell proliferation","volume":"176","author":"Gedaly","year":"2012","journal-title":"J Surg Res"},{"key":"10.1593\/tlo.12313_bib28","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/bjc.2012.70","article-title":"The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition","volume":"106","author":"Haagensen","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1593\/tlo.12313_bib29","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/1535-7163.MCT-12-0098","article-title":"Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer","volume":"11","author":"Williams","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1593\/tlo.12313_bib30","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1158\/0008-5472.CAN-08-4765","article-title":"PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers","volume":"69","author":"Wee","year":"2009","journal-title":"Cancer Res"},{"key":"10.1593\/tlo.12313_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.thj.6200327","article-title":"An investigation of the effects of the MEK inhibitor U0126 on apoptosis in acute leukemia","volume":"4","author":"James","year":"2003","journal-title":"Hematol J"},{"key":"10.1593\/tlo.12313_bib32","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1182\/blood.V99.9.3461","article-title":"Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK\/MAPK pathways in acute myelogenous leukemia","volume":"99","author":"Milella","year":"2002","journal-title":"Blood"},{"key":"10.1593\/tlo.12313_bib33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood.V97.6.1823","article-title":"Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1\/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling","volume":"97","author":"Morgan","year":"2001","journal-title":"Blood"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523313800393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523313800393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:28:09Z","timestamp":1761834489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523313800393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1936523313800393"],"URL":"https:\/\/doi.org\/10.1593\/tlo.12313","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase 1\/2 Activity","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1593\/tlo.12313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Neoplasia Press, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}